The role of ascorbic acid in the control of flowering time and the onset of senescence

Ascorbic acid (AA) is not only an important antioxidant, it also appears to link flowering time, developmental senescence, programmed cell death, and responses to pathogens through a complex signal transduction network. The biological activity of AA is defined by its oxidation and subsequent regeneration into the reduced form. Some studies suggest that the total endogenous level of AA influences induction of flowering and senescence. Both processes require the co-ordinated regulation of gene expression, which is mediated by various phytohormones. For example, gibberellins and salicylic acid are known to promote flowering, but inhibit or retard senescence in Arabidopsis. Ethylene and abscisic acid accelerate senescence. Ascorbic acid serves as an important co-factor for the synthesis of some of these hormones. Therefore, it is assumed that AA affects phytohormone-mediated signalling processes during the transition from the vegetative to the reproductive phase and the final stage of development, senescence. This review summarizes recent reports that investigate the effect of AA on flowering time and the onset of senescence. An attempt was made to bring these findings in context with previously characterized flowering and senescence pathways and a model is proposed that may explain how AA influences flowering and senescence both under long- and short-day conditions in Arabidopsis

Heart function analysis in cardiac patients with focus on sex-specific aspects

Cardiac function is best described by investigating the pressure-volume relationships. This information permits description in terms of the ventricular volume regulation graph (VRG), estimation of systolic elastance, evaluation of lusitropic properties, and assessment of ventriculo-arterial coupling. Current techniques yield noninvasive determination of cardiac compartmental volumes, along with systolic/diastolic arterial pressure, while ventricular end-diastolic pressure can be inferred from an echocardiography-based surrogate measure. Ventricular volume is known to vary with age, as well as to be affected by intrinsic cardiac disease and abnormalities of the vascular system. Moreover, 35 years ago it has been shown in healthy adults that left ventricular volume is significantly smaller in women compared to men. This important observation has serious implications for several metrics which are routinely used in clinical practice, e.g., ejection fraction. The remarkable difference between ventricular size in men and women is also a powerful starting point for the study of aging and the investigation of interventions such as exercise. In this review we evaluate sex-specific characteristics of the VRG and the implications for various cardiac patient populations, during basal conditions and intervention such as exercise